Group 1 - The core viewpoint of the article is that China Galaxy has given a "recommended" rating to Dize Pharmaceutical (688192.SH) based on significant developments in its product pipeline [1] - Shuwotini has received overseas approval for market launch, and multiple achievements have been selected for the 2025 WCLC [1] - The dual-target BTK has received fast track designation and is set to be showcased at the 2025 ASH [1]